Stille (STIL.ST) Stock Price

Stille Price

OMX·CLOSED
257.50
​
Market closed

Over the last 19 years Stille grew revenue by 8.7% annually, reaching 567.63 M SEK. Earnings per share have grown at 11.5% per year over the last 16 years. For Stille, the net margin of 9.8% is up versus 8.6% a few years ago. At today's price the dividend yield works out to roughly 0.70%. The payout ratio is around 34% of earnings. The dividend has grown at 6.7% per year over the past 9 years. The consensus 12-month price target for Stille is 243.78 SEK, about 5.3% below where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Stille stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille business model & stock analysis

Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings.

Frequently asked questions about Stille

Analysts currently set an average price target of 243.78 SEK for the Stille stock (median: 243.78 SEK), implying -5.5 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Stille stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Stille to generate revenue of 729.70 M SEK and earnings per share of 9.16 SEK.

Converted at the current exchange rate, the Stille share trades at 23.17 EUR (257.50 SEK).

The Stille share (STIL.ST) is listed on 2 stock exchanges, including: Stockholm (STIL.ST).

The expected revenue of Stille is 729.70 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Stille is 82.26 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Stille is currently 28.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Stille stock.

The price-to-sales ratio (P/S) of Stille is currently 3.17. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Stille stock.

The Eulerpool Quality Score for Stille is 7/10.

The ISIN of Stille is SE0000998650. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Stille is STIL.ST. The ticker symbol is used to trade Stille shares on the stock exchange.

Fair ValueTerminal
216.30 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website stille.se
Country
Sweden
Currency
SEK
Initial public offering
Aug 29, 1997
ISIN
SE0000998650
Cusip
W87818105
Market capitalization
2.31 B SEKMid Cap
52-Week Range
PEG
3.02
P/E ratio
P/Ee 2026
28.14
P/Ee 2027
22.35
P/Ee 2028
19.13
P/Ee 2029
—
P/Ee 2030
—
P/S
P/Se
3.17
EV/EBIT
31.71
P/B Ratio
3.27
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.81 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
0.79 %
Payout Ratio
29.17 %
Dividend growth Ø5Y
8.45 %
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Oct 23, 2026, 9:08 PM

Stille Peer Group

Stille Ticker

STOCKHOLM · STIL.STSTOCKHOLM · STIL.ST

Stille FIGI

STIL:SF · BBG001Y25FW1STILSEK:EO · BBG0058M6LW3STILSEK:XH · BBG0058M6LZ0STILSEK:XF · BBG0058M6M15STILSEK:XE · BBG0058M6M33STILSEK:XJ · BBG0058M6M42STILSEK:XL · BBG0058M6M51STILSEK:XG · BBG0058M6M60STILSEK:XO · BBG0058M6M79STILSEK:XS · BBG0058M6MC3STILSEK:XA · BBG0058M6MD2STILSEK:E1 · BBG0058M6MF0

All fundamentals and in-depth analysis of Stille

Our stock analysis for Stille stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stille. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.